LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

BACKGROUND: The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one or more bronchodilators according to the patient’s airflow limitation, their history of exacerbations, and symptoms. The LANTERN study evaluated the effect of the long-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Nanshan, Wang, Changzheng, Zhou, Xiangdong, Zhang, Nuofu, Humphries, Michael, Wang, Linda, Thach, Chau, Patalano, Francesco, Banerji, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461092/
https://www.ncbi.nlm.nih.gov/pubmed/26082625
http://dx.doi.org/10.2147/COPD.S84436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461092/
https://www.ncbi.nlm.nih.gov/pubmed/26082625
http://dx.doi.org/10.2147/COPD.S84436

Ejemplares similares